Recent paper on use of our Advax-CpG adjuvant in Herpes Simplex virus Vaccine development

This latest paper highlights a Herpes simplex virus vaccine being developed in collaboration with our Swedish partners. The Advax-CpG adjuvant in this herpes simplex vaccine is the same approach as we are using in our current COVID-19 vaccine.

Link to the paper: